Description
The 39th Annual “Critical Issues in Tumor Microenvironment” course continues its tradition of delivering cutting-edge analysis on the latest advancements in angiogenesis, metastasis, tumor immunology, and microenvironment research. This year’s program will introduce new sessions on cancer neuroscience and the role of Artificial Intelligence in cancer research, alongside in-depth discussions on CAR T-cell therapies, tumor metabolism, and the influence of the microbiome on cancer progression.
Led by an internationally renowned faculty, this course will provide expert insights from both clinical and laboratory research, highlighting critical gaps in current knowledge and outlining future directions in cancer research, drug development, and clinical applications.
Course Format
Four-day live online webinar
Expert-led didactic lectures
❓ Interactive Q&A sessions
Group case discussions
Attendees will have the opportunity to engage in open discussions, gain critical insights into emerging challenges and future opportunities, and explore novel therapeutic strategies and biomarker-driven treatments.
Course Objectives
By the end of this course, participants will:
✅ Analyze the tumor microenvironment – Understanding its role in angiogenesis, metastasis, and immune response
✅ Evaluate CAR T-cell therapies – Exploring their applications and challenges in cancer treatment
✅ Understand tumor metabolism & microbiome influence – Investigating their impact on cancer progression and therapy
✅ Explore AI & Cancer Neuroscience – Examining the latest applications of AI in oncology research and the growing field of cancer neuroscience
✅ Assess novel biomarkers & emerging therapies – Identifying their role in precision medicine and clinical translation
This course is ideal for oncologists, researchers, clinicians, and cancer biologists seeking a comprehensive, expert-led review of the latest findings and future directions in tumor microenvironment research.
